Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model Article

de Mello, Camilly P Pires, Tao, Xun, Kim, Tae Hwan et al. (2018). Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model . ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 62(9), 10.1128/AAC.00967-18

Open Access

cited authors

  • de Mello, Camilly P Pires; Tao, Xun; Kim, Tae Hwan; Vicchiarelli, Michael; Bulitta, Juergen B; Kaushik, Ajeet; Brown, Ashley N

sustainable development goals

authors

publication date

  • September 1, 2018

published in

keywords

  • IN-VIVO ACTIVITIES
  • Life Sciences & Biomedicine
  • Microbiology
  • POPULATION PHARMACOKINETICS
  • Pharmacology & Pharmacy
  • SYSTEM
  • Science & Technology
  • TRANSMISSION
  • VITRO
  • Zika virus
  • antiviral therapy
  • favipiravir
  • hollow-fiber infection model
  • mathematical modeling
  • pharmacodynamics
  • pharmacokinetics

Digital Object Identifier (DOI)

publisher

  • AMER SOC MICROBIOLOGY

volume

  • 62

issue

  • 9